This study is looking at how a combined respiratory muscle strength training program, called LVR+EMST (Lung Volume Recruitment and Expiratory Muscle Strength Training), affects people with ALS (Amyotrophic Lateral Sclerosis). Researchers want to see if this daily 5-week training can improve cough strength and breathing, and also how it impacts shortness of breath (dyspnea) and problems with speaking or swallowing (bulbar impairment). They will also look at how it affects the quality of life for patients and their caregivers. You might be able to join if you are 18-90 years old, have probable or definite ALS diagnosed within the last two years, haven't used LVR or EMST before, and have reduced peak cough flow (how fast you can cough). The study is currently unclear on its recruitment status.

Study design

This interventional study plans to enroll 34 participants with ALS. It uses a delayed start design where each participant serves as their own control.

What's involved

Participation involves three in-person evaluations and four weekly telehealth therapy sessions. You will also complete daily training for 5 weeks.

Compensation

Not stated in the trial record.

Follow-up

Your peak cough flow will be measured from baseline to the final evaluation at 10 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.